GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

Rating:
Overweight
AEGR
up 15.24 %

Aegerion Pharmaceuticals, Inc. (AEGR) rated Overweight by JP Morgan

Posted on: Wednesday,  Oct 3, 2012  8:25 AM ET by JP Morgan

JP Morgan rated Overweight Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) on 10/03/2012, when the stock price was $15.41. Since
then, Aegerion Pharmaceuticals, Inc. has gained 15.25% as of 01/27/2016's recent price of $17.76.
If you would have followed this JP Morgan's recommendation on AEGR, you would have gained 15.24% of your investment in 1211 days.

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.

JPMorgan is a leading financial services firm with one of the largest client franchises in the world. We partner with our clients to offer the most complete and innovative solutions in the industry to help them achieve their goals. For more than 200 years, we have taken a long-term approach to our clients and to the way we conduct business. Our firm has grown considerably in scale and scope, but our commitment to our core principle of doing "only first-class business... in a first-class way" has never been stronger.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/3/2012 8:25 AM Buy
None
15.41
as of 12/31/2012
1 Week up  0.51 %
1 Month up  15.89 %
3 Months up  64.69 %
1 YTD up  64.69 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy